Publications

  1. Hyperfractionated Accelerated Radiotherapy (HART) with maintenance chemotherapy for metastatic (M1-3) Medulloblastoma – a safety feasibility study.. Radiotherapy & Oncology 111(1), 41-46.
  2. Results of a Randomized Study of Preradiation Chemotherapy Versus Radiotherapy Alone for Nonmetastatic Medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. Journal of Clinical Oncology 21(8), 1581-1591.
  3. & Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. International Journal of Radiation Oncology*Biology*Physics 58(4), 1184-1193.
  4. -Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee. Journal of Clinical Oncology 23(31), 7951-7957.
  5. & Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. European Journal of Cancer 41(5), 727-734.

See more...

Supervision

  • Hippocampal Contouring and Sparing in brain cancer patients using advanced treatment planning techniques such as IMRT, VMAT and Proton therapy (current)

    Student name:
    MSc
    Other supervisor: Dr Richard Hugtenburg
    Other supervisor: Prof Roger Taylor
  • 'A rapid dosimentric assessment method using cone beam CT in prostate cancer patients' (current)

    Student name:
    PhD
    Other supervisor: Dr Richard Hugtenburg
    Other supervisor: Prof Roger Taylor
  • Tumour Volumetry and outcomes in rectal cancer (current)

    Student name:
    MD
    Other supervisor: Dr Richard Hugtenburg
    Other supervisor: Prof Roger Taylor